$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Operating Income Growth
13.97%
TTM · Period ending:

RARE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported13.97%period ending
Latest reported13.97%period ending
RARE TTM Operating Income YoY % (-79.93% → 13.97%)
Year-over-year change
High-resolution chart · PNG
What is operating income growth?
Year-over-year operating income growth rate.
RARE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 13.9698% | |
| -4.7116% | |
| -9.3879% | |
| 0.0478% | |
| -1.5401% | |
| 7.9733% | |
| 11.523% | |
| 5.8388% | |
| 9.6228% | |
| 18.4171% | |
| 12.8966% | |
| 12.2837% | |
| 2.157% | |
| -42.9519% | |
| -61.8242% | |
| -69.9911% | |
| -61.452% | |
| -40.1726% | |
| -30.3082% | |
| -15.6372% | |
| -14.2371% | |
| 15.2608% | |
| 29.0837% | |
| 22.1742% | |
| 21.8002% | |
| -1.1568% | |
| -19.119% | |
| -14.2175% | |
| -11.1664% | |
| -5.3074% | |
| -5.2395% | |
| -12.8992% | |
| -24.8499% | |
| -30.6283% | |
| -34.4769% | |
| -32.6342% | |
| -29.5532% | |
| -37.0402% | |
| -46.9709% | |
| -67.8695% | |
| -115.2687% | |
| -146.1076% | |
| -164.7267% | |
| -160.2029% | |
| -119.8602% | |
| -104.4809% | |
| -89.3984% | |
| -75.8922% | |
| -79.9293% |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance